|
|
||||||||
Ann Thorac Surg 1997;64:1782-1785
© 1997 The Society of Thoracic Surgeons
Cardiac Institute, Children's Hospital and Health Center, San Diego, California
Accepted for publication May 9, 1997.
Background. Type B interrupted aortic arch with ventricular septal defect is a complex congenital heart defect that may have associated left ventricular outflow tract obstruction. Surgical management has evolved from a two-stage approach to the currently favored single-stage approach. The following data summarize our experience with the two-stage approach over a 15-year period.
Methods. Between 1980 and 1995, 27 consecutive patients with type B interrupted aortic arch and ventricular septal defect underwent surgical management using the two-stage approach. There were 15 girls and 12 boys; 21 patients had the DiGeorge syndrome.
Results. Stage I was performed at a median age of 4 days. Twenty-six (96%) of 27 patients survived first-stage palliation. One patient survived stage I palliation but died before undergoing stage II. Twenty-five patients underwent second-stage repair at a median age of 6 weeks (range, 1 to 46 weeks). There were 2 early deaths and 1 late death. Actuarial analysis demonstrates 1- and 5-year survival rates of 85% and 81%, respectively. Twenty-two survivors have been followed up for an average of 8 ± 2 years. Freedom from reoperation for arch graft enlargement has been 86% at 3 years and 55% at 5 years. Freedom from reoperation for left ventricular outflow tract obstruction has been 82% at both 3 and 5 years.
Conclusions. The two-stage approach can achieve good mid- to long-term palliation of patients with type B interrupted aortic arch and ventricular septal defect. These results should provide a reference from which to gauge the long-term success of the single-stage approach.
Related Article
Ann. Thorac. Surg. 1997 64: 1785-1786.
This article has been cited by other articles:
![]() |
P. K. Mishra Management strategies for interrupted aortic arch with associated anomalies Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 569 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Brown, M. Ruzmetov, Y. Okada, P. Vijay, M. D. Rodefeld, and M. W. Turrentine Outcomes in patients with interrupted aortic arch and associated anomalies: a 20-year experience. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 666 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. McCrindle, C. I. Tchervenkov, I. E. Konstantinov, W. G. Williams, R. A. Neirotti, M. L. Jacobs, E. H. Blackstone, and For the members of the Congenital Heart Surgeons S Risk factors associated with mortality and interventions in 472 neonates with interrupted aortic arch: A Congenital Heart Surgeons Society study J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 343 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haas, C. S. Goldberg, R. G. Ohye, R. S. Mosca, and E. L. Bove Primary repair of aortic arch obstruction with ventricular septal defect in preterm and low birth weight infants Eur. J. Cardiothorac. Surg., June 1, 2000; 17(6): 643 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Backer and C. Mavroudis Congenital Heart Surgery Nomenclature and Database Project: patent ductus arteriosus, coarctation of the aorta, interrupted aortic arch Ann. Thorac. Surg., April 1, 2000; 69(4): S298 - 307. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |